Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA)

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 2, 2010, Pages 207-212

  Makdoumi, Karim ^a   Bäckman, Anders ^a   Mortensen, Jes ^a   Crafoord, Sven ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antimicrobial; Cross linking; Keratitis; Riboflavin; UVA

Indexed keywords

RIBOFLAVIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; KERATITIS; MICROBIAL ACTIVITY; NONHUMAN; PHOTOACTIVATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RADIATION EXPOSURE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRAVIOLET A RADIATION;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; HUMANS; KERATITIS; PHOTOSENSITIZING AGENTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RIBOFLAVIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRAVIOLET RAYS;

EID: 77949268948     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1231-2     Document Type: Article

References (36)

1. A Tsugita Y Okada K Uehara 1965 Photosensitized inactivation of ribonucleic acids in the presence of riboflavin Biochim Biophys Acta 103 360 363 1:CAS:528:DyaF2MXksFGltL4%3D 5319746
2. V Kumar O Lockerbie SD Keil PH Ruane MS Platz CB Martin JL Ravanat J Cadet RP Goodrich 2004 Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level Photochem Photobiol 80 15 21 10.1562/2003-12-23-RA-036.1 1:CAS:528:DC%2BD2cXnsVeju7w%3D 15339215
3. F Corbin 3rd 2002 Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer Int J Hematol 76 Suppl 2 253 257 10.1007/BF03165125 12430933 Review
4. JP AuBuchon L Herschel J Roger H Taylor P Whitley J Li R Edrich RP Goodrich 2005 Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction Transfusion 45 1335 1341 1:CAS:528:DC%2BD2MXps1Kns7k%3D 16078923
5. PH Ruane R Edrich D Gampp SD Keil RL Leonard RP Goodrich 2004 Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light Transfusion 44 877 885 10.1111/j.1537-2995.2004.03355.x 1:CAS:528:DC%2BD2cXlsFejsrY%3D 15157255 (Pubitemid 38738418)
6. LJ Cardo FJ Rentas L Ketchum J Salata R Harman W Melvin PJ Weina J Mendez H Reddy R Goodrich 2006 Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light Vox Sang 90 85 91 10.1111/j.1423-0410.2005.00736.x 1:STN:280: DC%2BD28%2FksVSlsQ%3D%3D 16430665 (Pubitemid 43381495)
7. LJ Cardo J Salata J Mendez H Reddy R Goodrich 2007 Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light Transfus Apher Sci 37 131 137 10.1016/j.transci.2007.07.002 17950672 (Pubitemid 350181574)
8. RP Goodrich RA Edrich J Li J Seghatchian 2006 The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends Transfus Apher Sci 35 5 17 10.1016/j.transci.2006.01.007 16935562 Review (Pubitemid 44354317)
9. JP AuBuchon L Herschel J Roger H Taylor P Whitley J Li R Edrich RP Goodrich 2005 Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction Transfusion 45 1335 1341 1:CAS:528:DC%2BD2MXps1Kns7k%3D 16078923
10. SM Picker A Steisel BS Gathof 2008 Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units Transfusion 48 1685 1692 10.1111/j.1537-2995. 2008.01778.x 18513255
11. HL Reddy AD Dayan J Cavagnaro S Gad J Li RP Goodrich 2008 Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation Transfus Med Rev 22 133 153 10.1016/j.tmrv.2007.12.003 18353253 Review
12. S Perez-Pujol R Tonda M Lozano B Fuste I Lopez-Vilchez AM Galan J Li R Goodrich G Escolar 2005 Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates Transfusion 45 911 919 10.1111/j.1537-2995.2005.04350.x 1:STN:280:DC%2BD2M3ptF2itQ%3D%3D 15934989 (Pubitemid 40798782)
13. G Wollensak 2006 Crosslinking treatment of progressive keratoconus: new hope Curr Opin Ophthalmol 17 356 360 10.1097/01.icu.0000233954.86723.25 16900027 Review (Pubitemid 44215044)
14. G Wollensak E Spoerl T Seiler 2003 Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus Am J Ophthalmol 135 620 627 10.1016/S0002-9394(02)02220-1 1:CAS:528:DC%2BD3sXjt1Knsbk%3D 12719068 (Pubitemid 36457967)
15. AJ Kanellopoulos PS Binder 2007 Collagen cross-linking (CCL) with sequential topography-guided PRK: a temporizing alternative for keratoconus to penetrating keratoplasty Cornea 26 891 895 10.1097/ICO.0b013e318074e424 17667633 (Pubitemid 47220571)
16. F Hafezi J Kanellopoulos R Wiltfang T Seiler 2007 Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis J Cataract Refract Surg 33 2035 2040 10.1016/j.jcrs.2007.07.028 18053900 (Pubitemid 350167516)
17. A Caporossi S Baiocchi C Mazzotta C Traversi T Caporossi 2006 Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study J Cataract Refract Surg 32 837 845 10.1016/j.jcrs.2006.01.091 16765803 (Pubitemid 43831548)
18. F Raiskup-Wolf A Hoyer E Spoerl LE Pillunat 2008 Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results J Cataract Refract Surg 34 796 801 10.1016/j.jcrs.2007.12.039 18471635 (Pubitemid 351615507)
19. E Coskunseven MR Jankov 2nd F Hafezi 2009 Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus J Refract Surg 25 371 376 10.3928/1081597X-20090401-02 19431928
20. C Wittig-Silva M Whiting E Lamoureux RG Lindsay LJ Sullivan GR Snibson 2008 A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results J Refract Surg 24 S720 S725 18811118
21. P Vinciguerra E Albè S Trazza P Rosetta R Vinciguerra T Seiler D Epstein 2009 Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking Ophthalmology 116 369 378 10.1016/j.ophtha.2008.09.048 19167087
22. E Schnitzler E Spörl T Seiler 2000 Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes, preliminary results in four patients Klin Monatsbl Augenheilkd 217 190 193 10.1055/s-2000-10344 1:STN:280:DC%2BD3M%2Fls1Olsw%3D%3D 11076351
23. HP Iseli MA Thiel F Hafezi J Kampmeier T Seiler 2008 Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts Cornea 27 590 594 10.1097/ICO.0b013e318169d698 18520510
24. T Micelli Ferrari M Leozappa M Lorusso E Epifani L Micelli Ferrari 2009 Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report Eur J Ophthalmol 19 295 297 19253251
25. SA Martins JC Combs G Noguera W Camacho P Wittmann R Walther M Cano J Dick A Behrens 2008 Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis Invest Ophthalmol Vis Sci 49 3402 3408 10.1167/iovs.07-1592 18408193
26. M Moshirfar JJ Meyer L Espandar 2007 Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis J Cataract Refract Surg 33 1978 1981 10.1016/j.jcrs.2007.07.019 17964409 (Pubitemid 47615385)
27. N Mamalis 2007 The increasing problem of antibiotic resistance J Cataract Refract Surg 33 1831 1832 10.1016/j.jcrs.2007.09.005 17964369 (Pubitemid 47616283)
28. J de la Cruz I Behlau R Pineda 2007 Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy J Cataract Refract Surg 33 1318 1321 10.1016/j.jcrs.2007.03.035 17586393 (Pubitemid 46951014)
29. M Moshirfar G Mirzaian V Feiz PC Kang 2006 Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery J Cataract Refract Surg 32 515 518 10.1016/j.jcrs.2005.12.108 16631067
30. V Jhanji N Sharma G Satpathy J Titiyal 2007 Fourth-generation fluoroquinolone-resistant bacterial keratitis J Cataract Refract Surg 33 1488 1489 10.1016/j.jcrs.2007.04.015 17662450 (Pubitemid 47088139)
31. CN McGhee R Niederer 2006 Resisting susceptibility: bacterial keratitis and generations of antibiotics Clin Experiment Ophthalmol 34 3 5 10.1111/j.1442-9071.2006.01164.x 16451250 (Pubitemid 43379362)
32. G Betanzos-Cabrera MA Juárez-Verdayes G González- González ME Cancino-Díaz JC Cancino-Díaz 2009 Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis Ophthalmic Res 42 43 48 10.1159/000219684 1:CAS:528:DC%2BD1MXnvF2kurk%3D 19478540
33. AJ O'Neill 2008 New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria Expert Opin Investig Drugs 17 297 302 10.1517/13543784.17.3.297 18321229 Review (Pubitemid 351578182)
34. GH Talbot 2008 What is in the pipeline for Gram-negative pathogens? Expert Rev Anti Infect Ther 6 39 49 10.1586/14787210.6.1.39 1:CAS:528: DC%2BD1cXhslejs7w%3D 18251663 Review
35. AM Nicasio JL Kuti DP Nicolau 2008 The current state of multidrug-resistant gram-negative bacilli in North America Pharmacotherapy 28 235 249 10.1592/phco.28.2.235 1:CAS:528:DC%2BD1cXit12hsbw%3D 18225969 Review (Pubitemid 351206969)
36. JE McGowan Jr 2006 Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum Am J Med 119 Suppl 1 S29 S36 10.1016/j.amjmed.2006.03.014 1:CAS:528:DC%2BD28XmvVylsLs%3D 16735148 discussion S62-70. Review (Pubitemid 43776143)